Xiaofei Li

Xiaofei Li

Auto-generated profile, based on publicly available information

Xiaofei Li

Department of Otolaryngology‐Head and Neck Surgery Shandong Provincial ENT Hospital Shandong University Jinan China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
DZDaogong Zhang
Daogong Zhang
WYWen-Qian Yu
Wen-Qian Yu
JLJia-Hui Liu
Jia-Hui Liu
LKLi-Gang Kong
Li-Gang Kong
NZNa Zhang
Na Zhang
HWhaibo wang
haibo wang
Ménière’s disease, a multifactorial disorder of the inner ear, is characterized by severe vertigo episodes and hearing loss. Although the role of immune responses in Ménière’s disease has been proposed, the precise mechanisms remain undefined. Here, we show that downregulation of serum/glucocorticoid-inducible kinase 1 is associated with activation of NLRP3 inflammasome in vestibular-resident macrophage-like cells from Ménière’s disease patients. Serum/glucocorticoid-inducible kinase 1 depletion markedly enhances IL-1β production which leads to the damage of inner ear hair cells and vestibular nerve. Mechanistically, serum/glucocorticoid-inducible kinase 1 binds to the PYD domain of NLRP3 and phosphorylates it at Serine 5, thereby interfering inflammasome assembly. Sgk−/− mice show aggravated audiovestibular symptoms and enhanced inflammasome activation in lipopolysaccharide-induced endolymphatic hydrops model, which is ameliorated by blocking NLRP3. Pharmacological inhibition of serum/glucocorticoid-inducible kinase 1 increases the disease severity in vivo. Our studies demonstrate that serum/glucocorticoid-inducible kinase 1 functions as a physiologic inhibitor of NLRP3 inflammasome activation and maintains inner ear immune homeostasis, reciprocally participating in models of Ménière’s disease pathogenesis.

20 November 2024 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
NZNa Zhang
Na Zhang
YSYongdong Song
Yongdong Song
HWHanyue Wang
Hanyue Wang
XLXiaofei Li
Xiaofei Li
YLYafeng Lyu
Yafeng Lyu
NLNa Li
Na Li
Ménière’s disease (MD) is a complex inner ear disorder characterized by a range of symptoms, with its pathogenesis linked to immune-related mechanisms. Our previous research demonstrated that IL-1β maturation and release can trigger cell pyroptosis, exacerbating the severity of the endolymphatic hydrops in a mouse model; however, the specific mechanism through which IL-1β influences MD symptoms remains unclear. This study conducted on patients with MD examined changes in protein signatures in the vestibular end organs (VO) and endolymphatic sac (ES) using mass spectrometry. Gene ontology and protein pathway analyses showed that differentially expressed proteins in the ES are closely related to adhesion, whereas those in the VO are related to synapse processes. Additionally, the study found elevated expression of Glutaminase (GLS) in the VO of MD patients compared to controls. Further investigations revealed that IL-1β increased glutamate levels by upregulating GLS expression in HEI-OC1 cells. Treatment with a GLS inhibitor or an IL-1β receptor antagonist alleviated auditory-vestibular dysfunction and reduced glutamate levels in mice with endolymphatic hydrops. These findings collectively suggest that imbalanced neurotransmitter release and immune responses contribute to the pathology of MD, potentially explaining the hearing loss and vertigo associated with the disease and offering new avenues for therapeutic interventions.

14 June 2023 in The Laryngoscope
Verified
Journal Article
Closed access
HJHuirong Jian
Huirong Jian
SWSiyue Wang
Siyue Wang
XLXiaofei Li
Xiaofei Li
HZHui Zhao
Hui Zhao
SLShanfeng Liu
Shanfeng Liu
DZDaogong Zhang
Daogong Zhang

10 April 2023 in The Laryngoscope
Verified
Journal Article
Closed access
XLXiaofei Li
Xiaofei Li
YLYafeng Lyu
Yafeng Lyu
YLYawei Li
Yawei Li
HJHuirong Jian
Huirong Jian
JWJing Wang
Jing Wang
DZDaogong Zhang
Daogong Zhang

1 April 2025 in Sensory Neuroscience
Verified
Journal Article
Open access
XLXiaofei Li
Xiaofei Li
HWHanyue Wang
Hanyue Wang
JWJing Wang
Jing Wang
MDMaoli Duan
Maoli Duan
YLYafeng Lyu
Yafeng Lyu
The inner ear is a critical sensory organ regulated by the immune system to maintain balance and respond to external stimuli. Immune cells like macrophages, lymphocytes, neutrophils, and natural killer cells play important roles in inner ear immunity. Inflammatory mediators, such as cytokines and chemokines, along with signaling pathways like NF‐κB, MAPK, and PI3K/AKT, regulate immune responses in the inner ear. Complement system activation and inflammatory vesicles further affect immune‐related inner ear pathology, causing damage to sensory epithelium, neurons, and blood vessels structurally. Many diseases involved in inner ear have been confirmed or speculated to be related to immune imbalance. Treatments for immune‐related inner ear diseases include corticosteroids, immunosuppressants, biological therapy agents, plasmapheresis, gene therapy, stem cell therapy, and surgical interventions like cochlear implantation. These treatments aim to regulate immune responses, reduce inflammation, and restore auditory and vestibular function. In conclusion, understanding the complex interaction between immunity and inner ear function is crucial for developing targeted therapeutic interventions for immune‐related inner ear diseases. Future research should focus on elucidating the immunological mechanisms behind these diseases and evaluating the efficacy and safety of novel treatment approaches.

1 June 2024 in Gland Surgery
Verified
Journal Article
Open access
PDF file
XLXiaofei Li
Xiaofei Li
YWYue Wang
Yue Wang
XLXiaoyi Li
Xiaoyi Li
LKLigang Kong
Ligang Kong
JDJuan J. Díez
Juan J. Díez
DZDaogong Zhang
Daogong Zhang
Background: There have been studies on the role of sperm-associated antigen 6 (SPAG6) in cytoskeleton formation and growth cone stability, but it is also unknown how spag6 affect tumor growth and development. The aim of this study was to clarify the role of SPAG6 in pan-cancer, with some findings about thyroid carcinoma (THCA) validated through experiments. Methods: We examined the role of SPAG6 in pan-cancer, with the data being collected from databases. Further analysis was conducted to assess its correlations with prognosis, gene heterogeneity, stemness, and tumor immunity. The interacting proteins of SPAG6 were also identified, and gene ontology enrichment analysis was performed to determine its biological function. We preliminarily confirmed the role of SPAG6 via in vitro experiments and immunofluorescence staining. Results: This study found that SPAG6 expression was differentially expressed in cancers and at various tumor stages and grades. In stomach and esophageal carcinoma (STES), stomach adenocarcinoma (STAD), kidney renal clear cell carcinoma (KIRC), lung squamous cell carcinoma (LUSC), and adrenocortical carcinoma (ACC), SPAG6 expression was correlated with gender. SPAG6 expression was also found to be correlated with prognostic value, with low expression being associated with poor prognosis. Furthermore, SPAG6 expression was positively linked with immune-related cells in HNSC, chemokine receptors in LUSC, and immune checkpoint genes in THCA. Furthermore, SPAG6 overexpression suppressed the malignant phenotypes of THCA cells, manifested by slower proliferation and decreased migration. The different SPAG6 expression in THCA led to different malignant phenotypes, which are involved in the upregulation of DNA repair, MYC targets, peroxisome, and G2M checkpoint. Conclusions: SPAG6 plays a significant role as an oncogene and can be used as a marker to predict the prognosis of cancer. SPAG6 influences both the tumor immune infiltration and microenvironment, making it a promising immunotherapeutic target for tumor therapy.